Jimmy Carter and Sarah Maldonado
  • About
    • Jimmy Carter
    • Sarah Maldonado
  • Blog
  • Contact
Select Page

FDA Updates Alzheimer’s Drug Testing Standards

by Jimmy Carter | Oct 9, 2018 | Alzheimer’s, Will Contests / Challenging a Will

In February 2018 the U.S. Food and Drug Administration (FDA) made a giant leap in modernizing its approach to its evaluation for new drugs for Alzheimer’s disease and other neurologic disease. This is welcome news to researchers who are searching for medications to...

New Study Links Connection Between Stroke and Dementia

by Jimmy Carter | Sep 18, 2018 | Dementia, Will Contests / Challenging a Will

A study recently conducted by The University of Exeter Medical School analyzed the data on stroke and dementia risk from 3.2 million individuals around the world. The data revealed that the link between stroke and dementia persisted even after taking into effect...

230 Years of Probate Law: Summary of the Greenwood-Baker Test of Testamentary Capacity 

by Jimmy Carter | Jul 3, 2018 | Cases, Will Contests / Challenging a Will

When contesting or challenging a will, modern courts use the Greenwood-Baker Test to determine whether a decedent possessed sufficient testamentary capacity to execute a will. The Greenwood-Baker test comes from two English cases: Greenwood v. Greenwood (decided in...

Improving Alzheimer’s Diagnosis 

by Jimmy Carter | Jun 28, 2018 | Alzheimer’s, Trust Disputes, Will Contests / Challenging a Will

As we’ve mentioned previously in this blog, the reluctance to assertively declare that a patient is suffering from Alzheimer’s does impact the course of will contest litigation.  Despite the prevalence of Alzheimer’s disease, there are many flaws in the diagnosis....

Alzheimer’s Risk Factors — And Lifestyle Prevention

by Jimmy Carter | Jun 21, 2018 | Alzheimer’s, Will Contests / Challenging a Will

Alzheimer’s disease, a type of dementia that causes impairment with memory, thinking and behavior, is commonly thought to be caused by factors that are out of our control: age, family history and heredity. Most individuals with the disease are 65 or older, have a...

Key to “Beeting” Alzheimer’s Discovered

by Jimmy Carter | Apr 17, 2018 | Will Contests / Challenging a Will

[vc_row][vc_column][vc_column_text margin_bottom=”5″ css=”.vc_custom_1525899319708{margin-bottom: 0px !important;}”]We’ve learned how the importance of maintaining a healthy diet throughout life plays a major role in preventing Alzheimer’s and...

Other Articles

  • Breakthrough: Blood Test Makes it Possible to Track Alzheimer’s Advancement 
    June 18, 2019
    A connection between Neurofilament light (NfL) levels present in the blood and Alzheimer’s disease was recently made in a study released by the JAMA Network.
  • New Study Might Diagnose CTE in Brains of the Living
    May 23, 2019
    A recent study published in the New England Journal of medicine revealed that brain scans of more than two dozen former NFL players found that the men had abnormal levels of the protein linked to chronic traumatic encephalopathy (C.T.E.), the degenerative brain disease we have discussed here that’s associated with repeated hits to the head.  
  • JUST PUT DOWN THE SUPPLEMENTS 
    May 15, 2019
    There have long been debates among established medical authorities and supplement manufacturers, especially when it comes to treating cognitive decline. Are the myriad of supplements currently on the market a genie in a bottle? Or is it better to focus on leading a healthy, balanced lifestyle? 
  • BREAKING NEWS: Promising Alzheimer’s Drug Fails in Late-Stage Human Trials 
    April 23, 2019
    Another big blow came to the Alzheimer’s research community late last month when pharmaceutical company Biogen and Eisai Co. announced on March 22 that they would terminate two late-stage studies of
  • Could a Noninvasive Eye Exam Preemptively Diagnose Alzheimer’s Disease? 
    April 8, 2019
    That’s what a recent study conducted at the Duke Eye Center suggests. The study of more than 200 people, published on March 11 in the journal Ophthalmology Retina, proposes that a quick, noninvasive
  • Tom Seaver Diagnosis Reignites Lyme Disease & Dementia Debate
    April 4, 2019
    AN ARTICLE IN The New York Times recently revealed that Tom Seaver, legendary pitcher and the most prominent player in New York Mets history, is stepping back from public life because of advancing dementia. It was recently discovered that Seaver, 74, has dementia. However, for many years he suffered from the effects of Lyme disease, which can cause cognitive problems similar to dementia.

Looking for a will or trust contest attorney?

Get In Touch
  • Follow
© 2025 JW Carter Law, PLLC. All rights reserved.

James W. Carter, IV is responsible for the content of this website.  Primary practice location: San Antonio, Texas.